GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (STU:BSX) » Definitions » PB Ratio

Boston Scientific (STU:BSX) PB Ratio : 6.75 (As of Dec. 15, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), Boston Scientific's share price is €85.50. Boston Scientific's Book Value per Share for the quarter that ended in Sep. 2024 was €12.66. Hence, Boston Scientific's PB Ratio of today is 6.75.

Warning Sign:

Boston Scientific Corp stock PB Ratio (=6.41) is close to 10-year high of 6.87

The historical rank and industry rank for Boston Scientific's PB Ratio or its related term are showing as below:

STU:BSX' s PB Ratio Range Over the Past 10 Years
Min: 2.6   Med: 4.27   Max: 6.87
Current: 6.41

During the past 13 years, Boston Scientific's highest PB Ratio was 6.87. The lowest was 2.60. And the median was 4.27.

STU:BSX's PB Ratio is ranked worse than
83.23% of 787 companies
in the Medical Devices & Instruments industry
Industry Median: 2.34 vs STU:BSX: 6.41

During the past 12 months, Boston Scientific's average Book Value Per Share Growth Rate was 9.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 13.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Boston Scientific was 54.00% per year. The lowest was -14.70% per year. And the median was 12.70% per year.

Back to Basics: PB Ratio


Boston Scientific PB Ratio Historical Data

The historical data trend for Boston Scientific's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific PB Ratio Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.48 3.28 3.67 3.70 4.25

Boston Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.17 4.25 5.12 5.56 5.88

Competitive Comparison of Boston Scientific's PB Ratio

For the Medical Devices subindustry, Boston Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's PB Ratio falls into.



Boston Scientific PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Boston Scientific's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=85.50/12.663
=6.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Boston Scientific  (STU:BSX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Boston Scientific PB Ratio Related Terms

Thank you for viewing the detailed overview of Boston Scientific's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.